January 8, 2004-- The results of the Rythmol Atrial Fibrillation Trial (RAFT), a randomized, double-blind, placebo-controlled clinical trial, published in the American Journal of Cardiology, [1] ...

This drug has a boxed warning. This is the most serious warning from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous.

Review the side-effects of Propafenone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Dec. 1, 2004 — Flecainide or propafenone can be safely self-administered by outpatients for control of recurrent atrial fibrillation, according to the results of a study published in the Dec. 2 issue ...

Learn everything you need to know about Propafenone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

In-hospital administration of flecainide and propafenone in a single oral loading dose has been shown to be effective and superior to placebo in terminating atrial fibrillation. We evaluated the ...

To investigate the effects of diltiazem, an L-type calcium channel blocker, and propafenone, a sodium channel blocker, on the inactivation and recovery kinetics of fKv1.4, a potassium channel that ...

Propafenone HCl 225mg, 325mg, 425mg; ext-rel caps. Propafenone, a Class 1C antiarrhythmic drug, has local anesthetic effects and a direct stabilizing action on myocardial membranes. The ...

Propafenone HCl 150mg, 225mg; scored tabs. Propafenone, a Class 1C antiarrhythmic drug, has local anesthetic effects and a direct stabilizing action on myocardial membranes. The electrophysiological ...

Propafenone is a class IC antiarrhythmic drug that acts by blocking sodium channels and has no effect on the action potential. The success rate of a single dose of propafenone converting atrial ...